Go to the list of all blogs
Niko Sharks's Avatar
published in Blogs
Oct 12, 2023
Solar Industry Stocks($JKS, $SPWR, $FSLR...) Surge with Notable 7.41% Weekly Gain🔥

Solar Industry Stocks($JKS, $SPWR, $FSLR...) Surge with Notable 7.41% Weekly Gain🔥

As concerns about climate change intensify, renewable energy is taking a larger slice of the global energy pie. Solar energy, in particular, has made significant strides thanks to technological advancements. The Solar Energy Industries Association has noted substantial growth in solar installations and forecasts continued progress. The solar sector offers a broad spectrum of investment opportunities: from equipment manufacturers to solar system installers, and from power producers to sellers. Firms like Tesla and Panasonic, although not primary solar companies, have ventured into solar panel manufacturing. Meanwhile, First Solar stands out in this capital-intensive industry, and Pattern Energy has seen its size triple since its 2013 IPO. With expectations that solar will eventually contribute to nearly half of the US's energy needs, this sector offers vast potential for forward-looking investors.

Tickers in Industry - $JKS, $SPWR, $FSLR, $SOL, $CSIQ, $NEP, $RUN, $SEDG, $CWEN

Swing Trader, Long Only: Valuation & Efficiency Model (TA&FA) - Annualized Return + 33%

Notable Companies

Pioneers leading the charge in this industry include:

  • First Solar (NASDAQ:FSLR)
  • SolarEdge Technologies (NASDAQ:SEDG)
  • Canadian Solar (NASDAQ:CSIQ)
  • SunPower Corp (NASDAQ:SPWR)

Market Cap

Companies in this sector vary significantly in terms of market capitalization. On average, the capitalization stands at 3.9B, with the spectrum ranging from a mere 210.8M (MUX) to a whopping 16.2B (FSLR).

High and Low Price Notable News

This week witnessed an average price growth of 5.25% across all stocks in the group. On the brighter side, Clearway Energy (CWEN) led the charge with a +14.02% surge, while Sunrun (RUN) and SunPower (SPWR) followed suit with gains of +11.91% and +6.12%, respectively.

Volume

In terms of volume, the past week saw an average growth of 10.49% across all stocks in the sector. NextEra Energy Partners made headlines on 9/30/23 with a record-breaking daily growth, an impressive 615% jump above its 65-Day Volume Moving Average.

Fundamental Analysis Ratings

While a deeper dive is needed for a comprehensive view, it's worth noting that the average fundamental analysis ratings for companies in this sector range from 1 (best) to 100 (worst).

As the global shift towards renewable energy continues, the solar industry is poised for significant growth, offering numerous opportunities for investors keen on harnessing the sun's potential.

SOL - SOL's stock trajectory has taken a bearish turn, witnessing a drop for three consecutive days as of October 05, 2023. Historical trends show that when SOL has faced a three-day decline, it continued to slide further in 266 out of 314 instances over the following month. The probability of this downtrend persisting stands at 85%.

CSIQ - On October 02, 2023, CSIQ's price breached its lower Bollinger Band, indicating a potential upward shift. Historically, when CSIQ moved past its lower Bollinger Band, it showed a tendency to rebound toward the middle band. From past observations, in 30 out of 36 such instances, the stock experienced further gains in the subsequent month. Given this, there's an 83% likelihood of the stock maintaining its upward momentum. Traders might look into purchasing the stock or considering call options.

NEP - On October 04, 2023, NEP's Aroon Indicator signaled a potential downward shift, as evidenced by the AroonDown red line surpassing 70, while the AroonUp green line remained below 30 for three consecutive days. Such a pattern suggests that NEP might face a significant decline in the coming period. Given this bearish sign, traders could contemplate either offloading the stock or acquiring put options. Based on historical analysis from A.I.dvisor, out of 155 similar Aroon patterns, the stock declined in 99 instances, suggesting a 64% probability of a continued downtrend.

Related Ticker: JKS, SPWRQ, FSLR, SOL, CSIQ, XIFR, RUN, SEDG, CWEN

JKS's Stochastic Oscillator is staying in overbought zone for 5 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where JKS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

JKS broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for JKS entered a downward trend on July 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 06, 2026. You may want to consider a long position or call options on JKS as a result. In of 108 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for JKS just turned positive on July 31, 2026. Looking at past instances where JKS's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

JKS moved above its 50-day moving average on August 14, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where JKS advanced for three days, in of 278 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.373) is normal, around the industry mean (8.007). P/E Ratio (27.176) is within average values for comparable stocks, (119.256). JKS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.368). P/S Ratio (0.092) is also within normal values, averaging (7.844).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. JKS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. JKS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.

Notable companies

The most notable companies in this group are First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SolarEdge Technologies (NASDAQ:SEDG), Canadian Solar (NASDAQ:CSIQ).

Industry description

The alternative power generation industry consists of companies that operate power facilities converting non-conventional forms of energy into electricity. These energy forms are alternatives to fossil fuels, and many of them are derived from natural resources. Alternative energy forms include solar, wind, hydro, and geothermal steam. A major purpose behind using alternative energy – also called ‘clean’ energy - is to address concerns related to the more conventional fossil fuels, such as the latter’s high carbon dioxide emissions which is often considered a factor in global warming. Alternative power generation has been gaining traction in recent years, and could grow further in the future. Large organizations like Google have invested substantially in wind and solar energy-powered electricity. Some of the prominent U.S. companies operating in the alternative power generation industry includes Ormat Technologies, Inc., TerraForm Power, Inc. and NextEra Energy Partners LP.

Market Cap

The average market capitalization across the Alternative Power Generation Industry is 2.47B. The market cap for tickers in the group ranges from 10 to 118.24B. REOVF holds the highest valuation in this group at 118.24B. The lowest valued company is CDVM at 10.

High and low price notable news

The average weekly price growth across all stocks in the Alternative Power Generation Industry was -9%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -30%. ZEO experienced the highest price growth at 6%, while SMXT experienced the biggest fall at -92%.

Volume

The average weekly volume growth across all stocks in the Alternative Power Generation Industry was -52%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was -50%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 68
P/E Growth Rating: 41
Price Growth Rating: 68
SMR Rating: 83
Profit Risk Rating: 98
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
JKS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages in integrated solar power product manufacturing and operating

Industry AlternativePowerGeneration

Profile
Details
Industry
Electrical Products
Address
1 Yingbin Road
Phone
+86 7938588188
Employees
46511
Web
https://www.jinkosolar.com/en
Interact to see
Advertisement
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Coca-Cola (KO) reports Q4 2025 earnings on February 10, 2026, with consensus EPS of $0.56 and revenue of $12.05 billion. PepsiCo (PEP) beat Q4 2025 estimates on February 3, reporting adjusted EPS of $2.26 (vs. $2.24 expected) and revenue of $29.34 billion.
(AZN) AstraZeneca’s full-year 2025 results, set for February 10, 2026, cap a year of sustained growth amid competitive pressures. Following 21% total revenue growth in FY 2024 and 19% core EPS expansion, AZN has maintained momentum with 11% revenue growth through nine months of 2025. The report offers insight into:
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.